Lenalidomide for treatment of refractory aphthosis and neutrophilic pustulosis in familial pyrin-associated autoinflammation with neutrophilic dermatosis

Laura Poujade, Guillaume Sarrabay, Renaud Cezar, Quentin Samaran, Pierre Corbeau, Didier Bessis, Tu-Anh Tran

Open source

DOI
10.1093/rheumatology/kead294
Published
2023-06-14
Container
Rheumatology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/kead294,
  title = {Lenalidomide for treatment of refractory aphthosis and neutrophilic pustulosis in familial pyrin-associated autoinflammation with neutrophilic dermatosis},
  author = {Laura Poujade and Guillaume Sarrabay and Renaud Cezar and Quentin Samaran and Pierre Corbeau and Didier Bessis and Tu-Anh Tran},
  year = {2023},
  journal = {Rheumatology},
  doi = {10.1093/rheumatology/kead294},
  url = {https://doi.org/10.1093/rheumatology/kead294}
}

RIS

TY  - JOUR
TI  - Lenalidomide for treatment of refractory aphthosis and neutrophilic pustulosis in familial pyrin-associated autoinflammation with neutrophilic dermatosis
AU  - Laura Poujade
AU  - Guillaume Sarrabay
AU  - Renaud Cezar
AU  - Quentin Samaran
AU  - Pierre Corbeau
AU  - Didier Bessis
AU  - Tu-Anh Tran
PY  - 2023
JO  - Rheumatology
DO  - 10.1093/rheumatology/kead294
UR  - https://doi.org/10.1093/rheumatology/kead294
ER  - 

APA

Poujade, L., Sarrabay, G., Cezar, R., Samaran, Q., Corbeau, P., Bessis, D., & Tran, T. (2023). Lenalidomide for treatment of refractory aphthosis and neutrophilic pustulosis in familial pyrin-associated autoinflammation with neutrophilic dermatosis. Rheumatology. https://doi.org/10.1093/rheumatology/kead294

Source records